Literature DB >> 17587829

PRL-3: a metastasis-associated phosphatase in search of a function.

Darrell C Bessette1, Patrick C W Wong, Catherine J Pallen.   

Abstract

The molecular and cellular events involved in cancer progression and metastasis remain much less well-defined than those involved in oncogenesis, despite the fact that cell metastasis is the major factor in cancer mortality. Thus, the discovery that the expression of a protein tyrosine phosphatase, protein of regenerating liver-3 (PRL-3), is upregulated in colon cancer metastases provided an exciting indication that the altered regulation of specific protein tyrosine phosphorylation events and signaling pathways might characterize these metastatic cells and/or be key in promoting the tumor-to-metastasis transition in this, and perhaps other, cancers of epithelial origin. However, the cellular substrate(s) of PRL-3 has not been identified, and little is known of PRL-3-mediated cellular signaling pathways. This review illustrates the significance of PRL-3 in promoting metastasis and the importance of determining the endogenous role of PRL-3. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587829     DOI: 10.1159/000101324

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  13 in total

Review 1.  Modulation of VEGF receptor 2 signaling by protein phosphatases.

Authors:  Federico Corti; Michael Simons
Journal:  Pharmacol Res       Date:  2016-11-23       Impact factor: 7.658

2.  Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells.

Authors:  Abdul Qader Omer Al-Aidaroos; Hiu Fung Yuen; Ke Guo; Shu Dong Zhang; Tae-Hoon Chung; Wee Joo Chng; Qi Zeng
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

Review 3.  The role and target potential of protein tyrosine phosphatases in cancer.

Authors:  Taolin Yi; Daniel Lindner
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

4.  PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.

Authors:  Cheng Zhang; Wei Tian; Lin Meng; Like Qu; Chengchao Shou
Journal:  J Mol Med (Berl)       Date:  2015-11-09       Impact factor: 4.599

5.  The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia.

Authors:  Jianbiao Zhou; Lip-Lee Cheong; Shaw-Cheng Liu; Phyllis S Y Chong; Sylvia Mahara; Chonglei Bi; Kelly Ok Ong; Qi Zeng; Wee Joo Chng
Journal:  Mol Cancer       Date:  2012-09-21       Impact factor: 27.401

6.  PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy.

Authors:  Jianbiao Zhou; Chonglei Bi; Wee-Joo Chng; Lip-Lee Cheong; Shaw-Cheng Liu; Sylvia Mahara; Kian-Ghee Tay; Qi Zeng; Jie Li; Ke Guo; Cheng Peow Bobby Tan; Hanry Yu; Daniel H Albert; Chien-Shing Chen
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

7.  Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.

Authors:  Xiaofang Xing; Shenyi Lian; Ying Hu; Ziyu Li; Lianhai Zhang; Xianzi Wen; Hong Du; Yongning Jia; Zhixue Zheng; Lin Meng; Chengchao Shou; Jiafu Ji
Journal:  J Transl Med       Date:  2013-12-13       Impact factor: 5.531

Review 8.  Unraveling the Anticancer Effect of Curcumin and Resveratrol.

Authors:  Aline Renata Pavan; Gabriel Dalio Bernardes da Silva; Daniela Hartmann Jornada; Diego Eidy Chiba; Guilherme Felipe Dos Santos Fernandes; Chung Man Chin; Jean Leandro Dos Santos
Journal:  Nutrients       Date:  2016-11-10       Impact factor: 5.717

9.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

10.  PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.

Authors:  Jianbo Xiong; Zhengrong Li; Yang Zhang; Daojiang Li; Guoyang Zhang; Xianshi Luo; Zhigang Jie; Yi Liu; Yi Cao; Zhibiao Le; Shengxing Tan; Wenyu Zou; Peitao Gong; Lingyu Qiu; Yuanyuan Li; Huan Wang; Heping Chen
Journal:  Oncol Rep       Date:  2016-08-23       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.